Your browser doesn't support javascript.
loading
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment.
Johnston, Jenessa N; Kadriu, Bashkim; Allen, Josh; Gilbert, Jessica R; Henter, Ioline D; Zarate, Carlos A.
Affiliation
  • Johnston JN; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. Electronic address: johnstonjenessa@gmail.com.
  • Kadriu B; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. Electronic address: bashkim.kadriu@nih.gov.
  • Allen J; The Alfred Centre, Department of Neuroscience, Monash University, Melbourne, Victoria, Australia. Electronic address: joshua.allen@monash.edu.
  • Gilbert JR; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. Electronic address: jessica.gilbert@nih.gov.
  • Henter ID; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. Electronic address: ioline.henter@nih.gov.
  • Zarate CA; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. Electronic address: zaratec@mail.nih.gov.
Neuropharmacology ; 226: 109422, 2023 03 15.
Article in En | MEDLINE | ID: mdl-36646310
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hallucinogens / Ketamine Type of study: Clinical_trials Language: En Journal: Neuropharmacology Year: 2023 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hallucinogens / Ketamine Type of study: Clinical_trials Language: En Journal: Neuropharmacology Year: 2023 Document type: Article Country of publication: Reino Unido